Larvol Delta - Longterm-Multidomain-Clinical-Response-to-Deucravacitinib-in-SLE-FourYear-Integrated-Analyses-From-a-Phase-2-Randomized-Study-and-Its-LongTerm-Extension

Sotyktu (deucravacitinib) - BMS

https://eppro02.ativ.me/web/page.php?nav=false&page=Session&project=ACR26&id=3570071

Ronald Van Vollenhoven, MD, PhD, MACR

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next